122 related articles for article (PubMed ID: 21885829)
1. Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner.
Ho-Tin-Noé B; Le Dall J; Gomez D; Louedec L; Vranckx R; El-Bouchtaoui M; Legrès L; Meilhac O; Michel JB
Circ Res; 2011 Oct; 109(9):1003-14. PubMed ID: 21885829
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor gamma agonist rosiglitazone attenuates oxyhemoglobin-induced Toll-like receptor 4 expression in vascular smooth muscle cells.
Wu Y; Zhao XD; Zhuang Z; Xue YJ; Cheng HL; Yin HX; Shi JX
Brain Res; 2010 Mar; 1322():102-8. PubMed ID: 20132800
[TBL] [Abstract][Full Text] [Related]
3. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
Demyanets S; Kaun C; Rychli K; Pfaffenberger S; Kastl SP; Hohensinner PJ; Rega G; Katsaros KM; Afonyushkin T; Bochkov VN; Paireder M; Huk I; Maurer G; Huber K; Wojta J
Basic Res Cardiol; 2011 Mar; 106(2):217-31. PubMed ID: 21174212
[TBL] [Abstract][Full Text] [Related]
4. Modulation of cardiac and aortic peroxisome proliferator-activated receptor-gamma expression by oxidative stress in chronically glucose-fed rats.
El Midaoui A; Wu L; Wang R; de Champlain J
Am J Hypertens; 2006 Apr; 19(4):407-12. PubMed ID: 16580578
[TBL] [Abstract][Full Text] [Related]
5. Selective activation of peroxisome proliferator-activated receptor (PPAR)alpha and PPAR gamma induces neoangiogenesis through a vascular endothelial growth factor-dependent mechanism.
Biscetti F; Gaetani E; Flex A; Aprahamian T; Hopkins T; Straface G; Pecorini G; Stigliano E; Smith RC; Angelini F; Castellot JJ; Pola R
Diabetes; 2008 May; 57(5):1394-404. PubMed ID: 18268046
[TBL] [Abstract][Full Text] [Related]
6. Pioglitazone inhibits homocysteine-induced migration of vascular smooth muscle cells through a peroxisome proliferator-activated receptor gamma-independent mechanism.
Li L; Gao PJ; Xi R; Wu CF; Zhu DL; Yan J; Lu GP
Clin Exp Pharmacol Physiol; 2008 Dec; 35(12):1471-6. PubMed ID: 18759864
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular smooth muscle cells.
Yamakawa K; Hosoi M; Koyama H; Tanaka S; Fukumoto S; Morii H; Nishizawa Y
Biochem Biophys Res Commun; 2000 May; 271(3):571-4. PubMed ID: 10814503
[TBL] [Abstract][Full Text] [Related]
8. Initiation of angiogenesis in atherosclerosis: smooth muscle cells as mediators of the angiogenic response to atheroma formation.
Ho-Tin-Noé B; Michel JB
Trends Cardiovasc Med; 2011 Oct; 21(7):183-7. PubMed ID: 22867696
[TBL] [Abstract][Full Text] [Related]
9. 2-hydroxy-4'-methoxychalcone inhibits proliferation and inflammation of human aortic smooth muscle cells by increasing the expression of peroxisome proliferator-activated receptor gamma.
Liu CS; Chang CC; Du YC; Chang FR; Wu YC; Chang WC; Hsieh TJ
J Cardiovasc Pharmacol; 2012 Apr; 59(4):339-51. PubMed ID: 22157260
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle-mediated delivery of pioglitazone enhances therapeutic neovascularization in a murine model of hindlimb ischemia.
Nagahama R; Matoba T; Nakano K; Kim-Mitsuyama S; Sunagawa K; Egashira K
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2427-34. PubMed ID: 22879581
[TBL] [Abstract][Full Text] [Related]
11. Rosiglitazone facilitates angiogenic progenitor cell differentiation toward endothelial lineage: a new paradigm in glitazone pleiotropy.
Wang CH; Ciliberti N; Li SH; Szmitko PE; Weisel RD; Fedak PW; Al-Omran M; Cherng WJ; Li RK; Stanford WL; Verma S
Circulation; 2004 Mar; 109(11):1392-400. PubMed ID: 14993120
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone reduces serum homocysteine levels, smooth muscle proliferation, and intimal hyperplasia in Sprague-Dawley rats fed a high methionine diet.
Murthy SN; Obregon DF; Chattergoon NN; Fonseca NA; Mondal D; Dunne JB; Diez JG; Jeter JR; Kadowitz PJ; Agrawal KC; McNamara DB; Fonseca VA
Metabolism; 2005 May; 54(5):645-52. PubMed ID: 15877295
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis.
Sueyoshi S; Mitsumata M; Kusumi Y; Niihashi M; Esumi M; Yamada T; Sakurai I
Pathol Res Pract; 2010 Jul; 206(7):429-38. PubMed ID: 20399568
[TBL] [Abstract][Full Text] [Related]
14. Expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells is upregulated in cystic medial degeneration of annuloaortic ectasia in Marfan syndrome.
Sakomura Y; Nagashima H; Aoka Y; Uto K; Sakuta A; Aomi S; Kurosawa H; Nishikawa T; Kasanuki H
Circulation; 2002 Sep; 106(12 Suppl 1):I259-63. PubMed ID: 12354743
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
16. Smooth Muscle Peroxisome Proliferator-Activated Receptor γ Plays a Critical Role in Formation and Rupture of Cerebral Aneurysms in Mice In Vivo.
Hasan DM; Starke RM; Gu H; Wilson K; Chu Y; Chalouhi N; Heistad DD; Faraci FM; Sigmund CD
Hypertension; 2015 Jul; 66(1):211-20. PubMed ID: 25916724
[TBL] [Abstract][Full Text] [Related]
17. PPAR gamma ligands, rosiglitazone and pioglitazone, inhibit bFGF- and VEGF-mediated angiogenesis.
Aljada A; O'Connor L; Fu YY; Mousa SA
Angiogenesis; 2008; 11(4):361-7. PubMed ID: 18810647
[TBL] [Abstract][Full Text] [Related]
18. Growth stimulation of COX-2-negative pancreatic cancer by a selective COX-2 inhibitor.
Eibl G; Takata Y; Boros LG; Liu J; Okada Y; Reber HA; Hines OJ
Cancer Res; 2005 Feb; 65(3):982-90. PubMed ID: 15705899
[TBL] [Abstract][Full Text] [Related]
19. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1592-604. PubMed ID: 17715259
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Burton JD; Castillo ME; Goldenberg DM; Blumenthal RD
Anticancer Drugs; 2007 Jun; 18(5):525-34. PubMed ID: 17414621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
